Dr. Stephen Michael Perazzelli, MD

Dr. Perazzelli practices at Saratoga Hospital in Saratoga Springs, New York, part of Albany Med Health System.

Dr. Perazzelli's NPI, 1295092237, was assigned on April 16, 2012. Dr. Perazzelli graduated from State University of New York Downstate Medical Center in 2012. Dr. Perazzelli holds New York license 279675.

Dr. Perazzelli's primary practice is Saratoga Hospital, at 211 Church Street, Saratoga Springs, NY 12866 in Saratoga County. The practice phone is (518) 587-3222.

Dr. Perazzelli's primary practice is Saratoga Hospital in Saratoga Springs, New York, part of Albany Med Health System. Dr. Perazzelli is also affiliated with Albany Medical Center. The medical group on file is Saratoga Hospital Medical Group Endocrinology and Diabetes. Dmand AI also links Dr. Perazzelli to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Perazzelli practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Perazzelli's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Perazzelli is licensed in New York.

CMS data shows 797 Medicare services from Dr. Perazzelli across 6 procedure codes in 2024, for 280 Medicare patients. Medicare paid $60,338 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 280 Medicare patients who saw Dr. Perazzelli in 2024. The largest group is 75 to 84, with 96 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 23% are also on Medicaid. Their average risk score is 2.37, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Perazzelli's median patient age at 70, with 48% women.

In 2024, Dr. Perazzelli wrote 352 Medicare Part D claims for 171 patients. 84% of them were for generic drugs. CMS names the drug for 96 of them, across 6 drugs with 11 or more claims each, at $9,070 in total drug cost. In 2023, CMS named 122 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 69 out of 100 for Dr. Perazzelli for performance year 2024, reported as part of a group. Dr. Perazzelli accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 2 general payments to Dr. Perazzelli from 2 drug and device companies in 2017. Food and beverage make up the largest share, 100% of the total. The Medicines Company paid the most, $20.

Dr. Perazzelli graduated from State University of New York Downstate Medical Center in 2012.